» Articles » PMID: 23677471

Control of Chronic Mycobacterium Tuberculosis Infection by CD4 KLRG1- IL-2-secreting Central Memory Cells

Overview
Journal J Immunol
Date 2013 May 17
PMID 23677471
Citations 99
Authors
Affiliations
Soon will be listed here.
Abstract

The bacille Calmette-Guérin vaccine provides very efficient protection in standard animal models of Mycobacterium tuberculosis challenge. We show in this article that although bacille Calmette-Guérin controlled M. tuberculosis growth for 7 wk of infection, the protection was gradually lost as the infection entered the chronic phase. The regrowth of M. tuberculosis coincided with an almost complete disappearance of IL-2-producing CD4 T cells. Booster vaccination with a subunit vaccine (Ag85B-ESAT-6+CAF01) expanded IL-2(+) CD4(+) T cell coexpressing either TNF-α or TNF-α/IFN-γ, and the maintenance of this population in the late stage of infection was associated with enhanced control of bacterial growth. The IL-2(+) CD4(+) T cell subsets were KLRG1(-) (nonterminally differentiated), were found to be CD62L(high), and further maintained a pronounced proliferative and cytokine-producing potential in the draining lymph nodes, when the animals were challenged 2 y postvaccination. These results suggest that the CD4(+) KLRG1(-) IL-2-secreting subsets are central memory T cells with the potential to continuously replenish the T cells at the site of infection and prevent attrition and functional exhaustion.

Citing Articles

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis.

De Voss C, Korompis M, Li S, Ateere A, McShane H, Stylianou E Front Immunol. 2025; 16:1540359.

PMID: 40018046 PMC: 11865049. DOI: 10.3389/fimmu.2025.1540359.


The combination of fusion proteins LT33 and LT28 induced strong protective immunity in mice.

He P, Wang J, Tan D, Hu L, Ma Y, Mi Y Front Immunol. 2024; 15:1450124.

PMID: 39650665 PMC: 11621036. DOI: 10.3389/fimmu.2024.1450124.


Host and pathogen genetic diversity shape vaccine-mediated protection to .

Cohen S, Plumlee C, Engels L, Mai D, Murray T, Jahn A Front Immunol. 2024; 15:1427846.

PMID: 39007152 PMC: 11239334. DOI: 10.3389/fimmu.2024.1427846.


Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal.

Hoseinpour R, Hasani A, Baradaran B, Abdolalizadeh J, Salehi R, Hasani A Heliyon. 2024; 10(4):e26193.

PMID: 38404880 PMC: 10884459. DOI: 10.1016/j.heliyon.2024.e26193.


Mucosal and systemic immune responses after a single intranasal dose of nanoparticle and spore-based subunit vaccines in mice with pre-existing lung mycobacterial immunity.

Vergara E, Tran A, Kim M, Mussa T, Paul M, Harrison T Front Immunol. 2023; 14:1306449.

PMID: 38130713 PMC: 10733481. DOI: 10.3389/fimmu.2023.1306449.